Bexxar (Tositumomab) is a dual-action therapy that combines the tumor-targeting ability of a monoclonal antibody and the therapeutic potential of radiation. Bexxar (Tositumomab) is a new radioimmunotherapy that has been shown to produce long remissions in some patients with Rituximab (Rituxan
Product Tags
Use spaces to separate tags. Use single quotes (') for phrases.